S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.01 (+0.92%)
AAPL   116.59 (+0.48%)
MSFT   215.23 (+0.64%)
FB   277.81 (+0.81%)
GOOGL   1,787.02 (+1.30%)
AMZN   3,195.34 (+0.32%)
TSLA   585.76 (+2.05%)
NVDA   530.45 (+0.20%)
BABA   276.48 (-0.45%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.19 (+0.55%)
T   29.03 (+0.14%)
NIO   54.00 (+0.58%)
F   9.09 (+0.11%)
ACB   10.47 (+20.21%)
NFLX   491.36 (+1.31%)
GILD   60.03 (+0.89%)
BA   216.50 (-0.51%)
DIS   147.13 (-1.31%)
S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.01 (+0.92%)
AAPL   116.59 (+0.48%)
MSFT   215.23 (+0.64%)
FB   277.81 (+0.81%)
GOOGL   1,787.02 (+1.30%)
AMZN   3,195.34 (+0.32%)
TSLA   585.76 (+2.05%)
NVDA   530.45 (+0.20%)
BABA   276.48 (-0.45%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.19 (+0.55%)
T   29.03 (+0.14%)
NIO   54.00 (+0.58%)
F   9.09 (+0.11%)
ACB   10.47 (+20.21%)
NFLX   491.36 (+1.31%)
GILD   60.03 (+0.89%)
BA   216.50 (-0.51%)
DIS   147.13 (-1.31%)
S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.01 (+0.92%)
AAPL   116.59 (+0.48%)
MSFT   215.23 (+0.64%)
FB   277.81 (+0.81%)
GOOGL   1,787.02 (+1.30%)
AMZN   3,195.34 (+0.32%)
TSLA   585.76 (+2.05%)
NVDA   530.45 (+0.20%)
BABA   276.48 (-0.45%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.19 (+0.55%)
T   29.03 (+0.14%)
NIO   54.00 (+0.58%)
F   9.09 (+0.11%)
ACB   10.47 (+20.21%)
NFLX   491.36 (+1.31%)
GILD   60.03 (+0.89%)
BA   216.50 (-0.51%)
DIS   147.13 (-1.31%)
S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.01 (+0.92%)
AAPL   116.59 (+0.48%)
MSFT   215.23 (+0.64%)
FB   277.81 (+0.81%)
GOOGL   1,787.02 (+1.30%)
AMZN   3,195.34 (+0.32%)
TSLA   585.76 (+2.05%)
NVDA   530.45 (+0.20%)
BABA   276.48 (-0.45%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.19 (+0.55%)
T   29.03 (+0.14%)
NIO   54.00 (+0.58%)
F   9.09 (+0.11%)
ACB   10.47 (+20.21%)
NFLX   491.36 (+1.31%)
GILD   60.03 (+0.89%)
BA   216.50 (-0.51%)
DIS   147.13 (-1.31%)
Log in
CNSX:TCAN

Transcanna Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
$0.91
MA: $1.07▼
$1.30
52-Week Range N/A
Volume129,024 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
TransCanna Holdings Inc. provides medical marijuana transportation and distribution services in Canada. Its services include transportation and distribution of cannabis and cannabis-related products; and branding and marketing services to cannabis-related clients. The company was founded in 2017 and is headquartered in Vancouver, Canada.
Read More

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.52 out of 5 stars


Industry, Sector and Symbol

Stock Exchange CNSX
Industry Business Services
Sub-IndustryN/A
SectorIndustrials
Current SymbolCNSX:TCAN
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.transcanna.com
Phone604-648-0516
EmployeesN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive TCAN News and Ratings via Email

Sign-up to receive the latest news and ratings for TCAN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Transcanna (CNSX:TCAN) Frequently Asked Questions

What stocks does MarketBeat like better than Transcanna?

Wall Street analysts have given Transcanna a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Transcanna wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Transcanna's key competitors?

Some companies that are related to Transcanna include A2B Australia Limited (A2B.AX) (A2B), Affinion Group (AFGR), ALS Limited (ALQ.AX) (ALQ), Brambles (BMBLF), Brambles Limited (BXB.AX) (BXB), BSA Limited (BSA.AX) (BSA), Cabcharge Australia Limited (CAB.AX) (CAB), Calian Group (CLNFF), CannaGrow (CGRW), Collection House Limited (CLH.AX) (CLH), Credit Intelligence Limited (CI1.AX) (CI1), CSG (CSV), Energy Action Limited (EAX.AX) (EAX), Excel (EXCC) and Experian (EXPGF).
View all competitors.

What other stocks do shareholders of Transcanna own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Transcanna investors own include OrganiGram (OGI), Aphria (APHA), Brookfield Property Partners (BPY), Cross Timbers Royalty Trust (CRT), Curaleaf (CURLF), Ivanhoe Mines Ltd. (IVN.TO) (IVN), Acreage (ACRGF), AGNC Investment (AGNC), InfraCap MLP ETF (AMZA) and Alliance Resource Partners (ARLP).

Who are Transcanna's key executives?

Transcanna's management team includes the following people:
  • Mr. James Pakulis, Chairman, Pres & CEO (Age 55)
  • Mr. Arni Johannson, Pres & Director
  • Mr. Greg Ball, Chief Financial Officer (Age 59)

What is Transcanna's stock symbol?

Transcanna trades on the CNSX under the ticker symbol "TCAN."

How do I buy shares of Transcanna?

Shares of TCAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Transcanna's official website?

The official website for Transcanna is www.transcanna.com.

How can I contact Transcanna?

The company can be reached via phone at 604-648-0516.

This page was last updated on 11/27/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.